Speech and language impairments in dementia

Journal of Applied Biomedicine

Volumn 14, Issue 2, 2016, Pages 97-103

  Klimova, Blanka ^a   Kuca, Kamil ^a,b  

^a UNIVERSITY OF HRADEC KRALOVE   (Czech Republic)

^b UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

Comparison; Dementia; Language impairments; Speech impairments; Strategies

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; POLYGLUTAMINE;

AGING; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; APRAXIA; APRAXIA OF SPEECH; ATAXIC APHASIA; CEREBROVASCULAR DISEASE; DEMENTIA; DIFFUSE LEWY BODY DISEASE; FRONTOTEMPORAL DEMENTIA; HUMAN; HUNTINGTON CHOREA; INTERPERSONAL COMMUNICATION; LANGUAGE DISABILITY; LEWY BODY; MEDICAL LITERATURE; MIXED DEPRESSION AND DEMENTIA; MULTIINFARCT DEMENTIA; PARKINSON DISEASE; REVIEW; SEMANTIC DEMENTIA; SENILE PLAQUE; SPEECH DISORDER;

EID: 84971434963     PISSN: 1214021X     EISSN: 12140287     Source Type: Journal    
DOI: 10.1016/j.jab.2016.02.002     Document Type: Review

References (58)

1. Alzheimer's Association, 2015. Alzheimer's Association Report 2015. Alzheimer's disease facts and figures. Alzheimer's Dement. 11, 332-384.
2. Amieva, H., Jacqmin-Gadda, H., Orgogozo, J.M., Le Carret, N., Helmer, C., Letenneur, L., Barberger-Gateau, P., Fabrigoule, C., Dartiques, J.F., 2005. The 9-year cognitive decline before dementia of the Alzheimer type: a prospective population-based study. Brain 128, 1093-1101.
3. Arab, L., Sabagh, M.N., 2010. Are certain life style habits associated with lower Alzheimer disease risk? Alzheimer's Dis. 20, 785-794.
4. Arrighi, H.M., Neumann, P.J., Lieberburg, I.M., Townsend, R.J., 2010. Lethality of Alzheimer disease and its impact on nursing home placement. Alzheimer Dis. Assoc. Disord. 24, 90-95.
5. Berger, J., 2011. The age of biomedicine: current trends in traditional subjects. J. Appl. Biomed. 9, 57-61.
6. Burns, A., Iliffe, S., 2009. Alzheimer's disease. BMJ 338, b158.
7. Cabral Soares, F., Oliveira, T.C.G., Macedo, L.D.D., Tomas, A.M., Picanco-Diniz, D.L.W., Bento-Torres, J., Bento-Torres, N.V.O., Picanco-Diniz, C.W., 2015. CANTAB object recognition and language tests to detect aging cognitive decline: an exploratory comparative study. Clin. Interv. Aging 10, 37-48.
8. Cardarelli, R., Kertesz, A., Knebl, J.A., 2010. Frontotemporal dementia: a review for primary care physicians. Am. Fam. Phys. 82, 1372-1377.
9. Chandra, S.R., Issac, T.G., Abbas, M.M., 2015. Apraxias in neurodegenerative dementias. Indian J. Psychol. Med. 37, 42-47.
10. Clare, L., Woods, R., 2001. Cognitive rehabilitation in dementia. Spec. Issue Neuropsychol. Rehabil. 11, 193-517.
11. Colman, K.S., Koerts, J., van Beilen, M., Leenders, K.L., Post, W.J., Bastiaanse, R., 2009. The impact of executive functions on verb production in patients with Parkinson's disease. Cortex 45, 930-942.
12. de la Torre, J.C., 2002. Alzheimer disease as a vascular disorder. Stroke 33, 1152-1162.
13. de las Cuevas, N., Munoz, U., Bartolome, F., Esteras, N., Alquezar, C., Martin-Requero, A., 2010. Cell cycle and Alzheimer's disease: studies in non-neuronal cells. J. Appl. Biomed. 8, 121-130.
14. Farlow, M.R., Schmitt, F., Aarsland, D., Grossberg, G.T., Somogyi, M., Meng, X., 2013. Comparing clinical profiles in Alzheimer's disease and Parkinson's disease dementia. Dement. Geriatr. Cogn. Dis. Extra 3, 281-290.
15. Ferris, S.H., Farlow, M., 2013. Language impairments in Alzheimer's disease and benefits of acetylcholinesterase inhibitors. Clin. Interv. Aging 8, 1007-1014.
16. Gorno-Tempini, M.L., Hillis, A.E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S.F., Ogar, J.M., Rohrer, J.D., Black, S., Boeve, B.F., Manes, F., Dronkers, N.F., Vandenberghe, R., Rascovsky, K., Patterson, K., Miller, B.L., Knopman, D.S., Hodges, J.R., Mesulam, M.M., Grossman, M., 2011. Classification of primary progressive aphasia and its variants. Neurology 76, 1006-1014.
17. Harding, A.J., Broe, G.A., Halliday, G.M., 2002. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 125, 391-403.
18. Hoehn, M., Yahr, M., 1967. Parkinsonism: onset, progression and mortality. Neurology 17, 427-442.
19. Jagust, W., 2001. Untangling vascular dementia. Lancet 358, 2097.
20. Kivipelto, M., Solomon, A., 2007. Alzheimer's disease - the ways of prevention. J. Nutr. Health Aging 12, 89S-94S.
21. Klimova, B., Kuca, K., 2015. Alzheimer's disease: potential preventive, non-invasive, intervention strategies in lowering the risk of cognitive decline - a review study. J. Appl. Biomed. 13, 257-261.
22. Klimova, B., Maresova, P., Valis, M., Hort, J., Kuca, K., 2015. Alzheimer's disease and language impairments: social intervention and medical treatment. Clin. Interv. Aging 10, 1401-1408.
23. Krapp, K.M., 2002. The Gale Encyclopedia of Nursing & Allied Health, sixth ed. Gale Group, Detroit.
24. Langa, K.M., 2015. Is the risk of Alzheimer's disease and dementia declining? Alzheimer's Res. Therapy 7, 1-4.
25. Langa, K.M., Foster, N.L., Larson, E.B., 2004. Mixed dementia: emerging concepts and therapeutic implications. J. Am. Med. Asoc. 292, 2901-2908.
26. Laws, K.R., Duncan, A., Gale, T.M., 2010. Normal semantic-phonemic fluency discrepancy in Alzheimer's disease? A meta-analytic study. Cortex 46, 595-601.
27. Lirani-Silva, C., Mourao, L.F., Gobbi, L.T., 2015. Dysarthria and quality of life in neurologically healthy elderly and patients with Parkinson's disease. Codas 27, 248-254.
28. Liu, L., Luo, X.G., Dy, C.L., Ren, Y., Feng, Y., Yu, H.M., Shang, H., He, Z.Y., 2015. Characteristics of language impairment in Parkinson's disease and its influencing factors. Transl. Neurodegener. 4, 2.
29. Longe, J.L., 2011. The Gale Encyclopedia of Children's Health: Infancy through Adolescence, second ed. Gale Group, Detroit.
30. Lyketsos, C.G., Carrillo, M.C., Ryan, J.M., Khachaturian, A.S., Trzepacz, P., Amatniek, J., Cedarbaum, J., Brashear, R., Miller, D.S., 2011. Neuropsychiatric symptoms in Alzheimer's disease. Alzheimer's Dement. 7, 532-539.
31. Madhavan, A., Whitwell, J.L., Weigand, S.D., Duffy, J.R., Strand, E. A., Machulda, M.M., Tosakulwong, N., Senjem, M.L., Gunter, J. L., Lowe, V.J., Petersen, R.C., Jack, C.R., Josephs, K.A., 2013. FDG PET and MRI in logopenic primary progressive aphasia versus dementia of the Alzheimer's type. PLOS ONE 8, e62471.
32. Malek, N., Grosset, D.G., 2015. Medication adherence in patients with Parkinson's disease. CNS Drugs 29, 47-53.
33. Manenti, R., Repetto, C., Bentrovato, S., Marcone, A., Bates, E., Cappa, S.F., 2004. The effects of ageing and Alzheimer's disease on semantic and gender priming. Brain 127, 2299-2306.
34. Maresova, P., Klimova, B., Kuca, K., 2015. Alzheimer's disease: cost cuts call for novel drugs development and national strategy. Ces. Slov. Farm. 64, 25-30.
35. McKhann, G.M., Knopmanc, D.S., Chertkowd, H., Hyman, B.T., Jack, C.R., Kawash, C.H., Klunk, W.E., Koroshetz, W.J., Manly, J.J., Mayeux, R., Mohs, R.C., Morris, J.C., Rossor, M.N., Scheltens, P., Carillo, M.C., Thies, B., Weintraub, S., Phelps, C. H., 2011. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's Dement. 7, 263-269.
36. Nieoullon, A., 2011. Neurodegenerative diseases and neuroprotection: current views and prospects: review article. J. Appl. Biomed. 9, 173-183.
37. Obeso, I., Casabona, E., Bringas, M.L., Alvarez, L., Jahanshahi, M., 2012. Semantic and phonemic verbal fluency in Parkinson's disease: influence of clinical and demographic variables. Behav. Neurol. 25, 111-118.
38. Paillard, T., 2015. Preventive effects of regular physical exercise against cognitive decline and the risk of dementia with age advancement. Sports Med. 4, 1-6.
39. Perl, D.P., Pendlebury, W.W., 1986. Neuropathology of dementia. Neurol. Clin. 4, 355-368.
40. Pohanka, M., 2011. Alzheimer's disease and related neurodegenerative disorders: implication and counteracting of melatonin. J. Appl. Biomed. 9, 185-196.
41. Prince, M., Guerchet, M., Prina, M., 2013. Alzheimer's Disease International. Policy brief for heads of government: the global impact of dementia 2013-2050, London. Alzheimer's Dis. Int..
42. Rabinovici, G.D., Miller, B.L., 2010. Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management. CNS Drugs 24, 375-398.
43. Rossor, M.N., 2001. Can the physician predict the neuropathologist? In: Tolnay, M., Probst, A. (Eds.), Neuropathology and Genetics of Dementia. Springer Science +Business Media, New York, pp. 1-4.
44. Savundranayagam, M.Y., Hummert, M.L., Montgomery, R.J., 2005. Investigating the effects of communication problems on caregiver burden. J. Gerontol. B: Psychol. Sci. Soc. Sci. 60 48-S55.
45. Shivanand, P., 2009. Review on Alzheimer's disease: its cause, symptoms, and treatment at worldwide. IJABPT 1, 112-120.
46. Sperling, R.A., Aisen, P.S., Beckett, L.A., Bennett, D.A., Craft, S., Fagan, A.M., Iwatsubo, T., Jack, C.R., Kaye, J., Montine, T.J., Park, D.C., Reiman, E.M., Rowe, C.C., Siemers, E., Stern, Y., Yaffe, K., Carrillo, M.C., Thies, B., Morrison-Bogorad, M., Wagster, M.V., Phelps, C.H., 2011. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's Dement. 7, 280-292.
47. Starkstein, S.E., Preziosi, T.J., Berthier, M.L., Bolduc, P.L., Mayberg, H.S., Robinson, R.G., 1989. Depression and cognitive impairment in Parkinson's disease. Brain 112, 1141-1153.
48. Stern, Y., Albert, S., Tang, M.X., Tsai, W.Y., 1999. Rate of memory decline in AD is related to education and occupation: cognitive reserve? Neurology 53, 1942-1957.
49. Tang-Wai, D.F., Graham, N.L., 2008. Assessment of language function in dementia. Geriatr. Aging 11, 103-110.
50. Thackery, E., Harris, M. (Eds.), 2003. The Gale Encyclopedia of Mental Disorders. third ed. Thompson Gale, Detroit.
51. Valis, M., 2014. Duodopa u pokrocile Parkinsonovy nemoci. (Duodopa in advanced Parkinson's disease in clinical practice - a case report). Neurol. Praxi 15, 210-212.
52. Verghese, J., Lipton, R.B., Katz, M.J., Hall, C.B., Derby, C.A., Kuslansky, G., Ambrose, A.F., Sliwinski, M., Buschke, H., 2003. Leisure activities and the risk of dementia in the elderly. N. Engl. J. Med. 348, 2508-2516.
53. Vestal, L., Smith-Olinde, L., Hicks, G., Hutton, T., Hart, J., 2006. Efficacy of language assessment in Alzheimer's disease: comparing in-person examination and telemedicine. Clin. Interv. Aging 1, 467-471.
54. Vuorinen, E., Laine, M., Rinne, J., 2000. Common pattern of language impairment in vascular dementia and in Alzheimer's disease. Alzheimer Dis. Assoc. Disord. 14, 81-86.
55. Warren, J.D., Rohrer, J.D., Rossor, M.N., 2013. Clinical review. Frontotemporal dementia. BMJ 6, f4827.
56. Zanini, S., Tavano, A., Fabbro, F., 2010. Spontaneous language production in bilingual Parkinson's disease patients: evidence of greater phonological, morphological and syntactic impairments in native language. Brain Lang. 113, 84-89.
57. Zekry, D., Hauw, J.J., Gold, G., 2002. Mixed dementia: epidemiology, diagnosis, and treatment. J. Am. Geriatr. Soc. 50, 1431-1438.
58. Zientz, J., Rackley, A., Chapman, S.B., Hopper, T., Mahendra, N., Kim, E.S., Cleary, S., 2007. Evidence-based practice recommendations for dementia: educating caregivers on Alzheimer's disease and training communication strategies. J. Med. Speech Lang. Pathol. 15, liii-lxiv.